Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Spekulatius who wrote (63140)	1/11/2020 8:42:36 AM
From: bruwin	Read Replies (1) of 78751

CVS seems to exhibit similar ratios to WBA with slim margins and only 1.8% left over on its Bottom Line, but with the added aspect of having more of a "debt expense" problem removing about 26% of the only 4.8% of Revenue left over at the EBITDA level .... However it has shown a fairly consistent rise in its Revenue stream over the last 8 Quarters ...... In its first 5 Quarters below, the Net Income numbers did not rise with the Revenue, but that has since shown improvement in the last 3 Quarters ..... That recent Bottom Line improvement seems to have been reflected in CVS's share price over that period .... Seems to me that the $80 a share price is possibly a number to keep an eye on in conjunction with what comes out in CVS's future Quarterlies ......

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next